Manipulation of Panx1 Activity Increases the Engraftment of Transplanted Lacrimal Gland Epithelial Progenitor Cells
Overview
Authors
Affiliations
Purpose: Sjögren's syndrome is a systemic chronic autoimmune inflammatory disease that primarily targets the salivary and lacrimal glands (LGs). Currently there is no cure; therefore, cell-based regenerative therapy may be a viable option. LG inflammation is facilitated by extracellular ATP and mediated by the Pannexin-1 (Panx1) membrane channel glycoprotein. We propose that suppression of inflammation through manipulation of Panx1 activity can stimulate epithelial cell progenitor (EPCP) engraftment.
Methods: The expression of pannexins in the mouse and human LG was assayed by qRT-PCR and immunostaining. Acute LG inflammation was induced by interleukin-1α (IL1α) injection. Prior to EPCP transplantation, IL1α-injured or chronically inflamed LGs of thrombospondin-1-null mice (TSP-1-/-) were treated with the Panx1-specific blocking peptide (10panx) or the self-deliverable RNAi (sdRNAi). The efficacy of cell engraftment and the area of inflammation were analyzed by microscopy.
Results: Panx1 and Panx2 were detected in the mouse and human LGs. Panx1 and proinflammatory factors were upregulated during acute inflammation at days 1 to 3 after the IL1α injection. The analysis of EPCP engraftment demonstrated a significant and reproducible positive correlation between the 10panx peptide or Panx1 sdRNAi treatment and the number of engrafted cells. Similarly, treatment of the LG of the TSP-1-/- mouse (mouse model of chronic LG inflammation) by either Panx1 or Caspase-4 (also known as Casp11) sdRNAi showed a significant decrease in expression of proinflammatory markers and the lymphocyte infiltration.
Conclusions: Our results suggest that blocking Panx1 and/or Casp4 activities is a beneficial strategy to enhance donor cell engraftment and LG regeneration through the reduction of inflammation.
Advanced Biomaterials for Lacrimal Tissue Engineering: A Review.
Wu K, Dave A, Daigle P, Tran S Materials (Basel). 2024; 17(22).
PMID: 39597252 PMC: 11595815. DOI: 10.3390/ma17225425.
Roles of the Caspase-11 Non-Canonical Inflammasome in Rheumatic Diseases.
Yi Y Int J Mol Sci. 2024; 25(4).
PMID: 38396768 PMC: 10888639. DOI: 10.3390/ijms25042091.
Emerging functions of thrombospondin-1 in immunity.
Kaur S, Roberts D Semin Cell Dev Biol. 2023; 155(Pt B):22-31.
PMID: 37258315 PMC: 10684827. DOI: 10.1016/j.semcdb.2023.05.008.
Delcroix V, Mauduit O, Yang M, Srivastava A, Umazume T, de Paiva C Int J Mol Sci. 2023; 24(5).
PMID: 36901740 PMC: 10001612. DOI: 10.3390/ijms24054309.
Finburgh E, Mauduit O, Noguchi T, Bu J, Abbas A, Hakim D Invest Ophthalmol Vis Sci. 2023; 64(1):21.
PMID: 36715672 PMC: 9896866. DOI: 10.1167/iovs.64.1.21.